Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. Industriels
  2. Médicament
  3. FASENRA (benralizumab)
  • icone plus
  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte
  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités
Listen Listen
Add to my selection
  • History
  • Technical informations
Share
Share on
Facebook share - facebook.com - new window
Tweeter share - Partager sur Twitter - twitter.com - new window
LinkedIn share - linkedin.com - new window
Print

FASENRA (benralizumab)

Medicine - Posted on Aug 30 2024
Active substance (DCI)
  • benralizumab
history (1)
  • 8/29/24

    FASENRA (benralizumab) - Granulomatose éosinophilique

    Autorisation d’accès précoce refusée à la spécialité FASENRA (benralizumab) dans l’indication « traitement des patients adul...
    icône flèche
Technical information
ATC code
  • R03DX10
Manufacturer
ASTRAZENECA
Presentation

FASENRA 30 mg - Solution injectable en seringue préremplie
(UCD : 34008 944 427 6 9) - (Code CIP : 34009 301 329 4 4)

All our publications
    Autoimmune diseases Bronchial diseases Congenital, genetic and rare diseases Drug therapy Pulmonary and pleural diseases Vascular diseases - miscellaneous

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
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
gWXgn3Dg8aYUqaYG